ChemoCentryx, Inc. to Present at Two Upcoming Investor Conferences

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, Calif., Sept. 4, 2013 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. (Nasdaq:CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC